UBS Group
EHC icon

UBS Group’s Encompass Health EHC Stock Holding History

UBS Group’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,800
Closed -$1.57M – 10447
2025
Q2 		$1.57M Buy
+12,800
New +$1.46M ﹤0.01% 5050
2022
Q1 		– Sell
-73,409
Closed -$3.81M – 10397
2021
Q4 		$3.81M Buy
+73,409
New +$3.79M ﹤0.01% 3131
2020
Q1 		– Sell
-21,495
Closed -$1.19M – 8052
2019
Q4 		$1.19M Buy
+21,495
New +$1.17M ﹤0.01% 4043

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group's EHC Position: Q2 2026 in Review

UBS Group reduced its Encompass Health (EHC) stake by 44% in Q2 2026, selling an estimated $22.7M and leaving 276,612 shares worth $28M. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

UBS Group first reported a position in EHC in Q4 2014 and has held it in 47 quarters since. The position peaked at $48M in Q1 2026. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • UBS Group held 276,612 shares of Encompass Health worth $28M as of Q2 2026.
  • UBS Group sold 219,524 Encompass Health shares in Q2 2026, an estimated $22.7M.
  • Encompass Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2335 holding.
  • UBS Group first reported a position in Encompass Health in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Encompass Health position peaked at $48M in Q1 2026.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.